Insulet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. 

CEO
Ashley A. McEvoy
CEOAshley A. McEvoy
Employees
3,900
Employees3,900
Headquarters
Acton, Massachusetts
HeadquartersActon, Massachusetts
Founded
2000
Founded2000
Employees
3,900
Employees3,900

PODD Key Statistics

Market cap
23.42B
Market cap23.42B
Price-Earnings ratio
96.53
Price-Earnings ratio96.53
Dividend yield
Dividend yield
Average volume
685.35K
Average volume685.35K
High today
$336.56
High today$336.56
Low today
$328.60
Low today$328.60
Open price
$333.93
Open price$333.93
Volume
400.30K
Volume400.30K
52 Week high
$353.50
52 Week high$353.50
52 Week low
$230.05
52 Week low$230.05

Stock Snapshot

As of today, Insulet(PODD) shares are valued at $332.70. The company's market cap stands at 23.42B, with a P/E ratio of 96.53.

During the trading session on 2025-11-16, Insulet(PODD) shares reached a daily high of $336.56 and a low of $328.60. At a current price of $332.70, the stock is +1.2% higher than the low and still -1.1% under the high.

Trading activity shows a volume of 400.3K, compared to an average daily volume of 685.35K.

Over the past 52 weeks, Insulet(PODD) stock has traded between a high of $353.50 and a low of $230.05.

Over the past 52 weeks, Insulet(PODD) stock has traded between a high of $353.50 and a low of $230.05.

PODD News

Simply Wall St 2d
How Investors May Respond To Insulet Raising Guidance After Omnipod-Driven Q3 Sales Surge

Insulet Corporation recently reported its third quarter results, posted US$706.2 million in sales, US$87.6 million in net income, and raised its revenue guidanc...

How Investors May Respond To Insulet Raising Guidance After Omnipod-Driven Q3 Sales Surge
TipRanks 3d
Insulet’s Promising Growth and Strategic Initiatives Earn a Buy Rating from Marie Thibault

In a report released today, Marie Thibault from BTIG maintained a Buy rating on Insulet, with a price target of $370.00. Meet Your ETF AI Analyst Discover how T...

Analyst ratings

83%

of 29 ratings
Buy
82.8%
Hold
17.2%
Sell
0%

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.